skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A novel assessment of nefazodone-induced hERG inhibition by electrophysiological and stereochemical method

Journal Article · · Toxicology and Applied Pharmacology
;  [1];  [2]; ; ; ;  [1];  [3];  [2]
  1. Drug Discovery Platform Technology Research Group, Korea Research Institute of Chemical Technology, Daejeon (Korea, Republic of)
  2. Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Daejeon (Korea, Republic of)
  3. College of Veterinary Medicine, Kyungpook National University, Daegu (Korea, Republic of)

Nefazodone was used widely as an antidepressant until it was withdrawn from the U.S. market in 2004 due to hepatotoxicity. We have investigated methods to predict various toxic effects of drug candidates to reduce the failure rate of drug discovery. An electrophysiological method was used to assess the cardiotoxicity of drug candidates. Small molecules, including withdrawn drugs, were evaluated using a patch-clamp method to establish a database of hERG inhibition. Nefazodone inhibited hERG channel activity in our system. However, nefazodone-induced hERG inhibition indicated only a theoretical risk of cardiotoxicity. Nefazodone inhibited the hERG channel in a concentration-dependent manner with an IC{sub 50} of 45.3 nM in HEK-293 cells. Nefazodone accelerated both the recovery from inactivation and its onset. Nefazodone also accelerated steady-state inactivation, although it did not modify the voltage-dependent character. Alanine mutants of hERG S6 and pore region residues were used to identify the nefazodone-binding site on hERG. The hERG S6 point mutants Y652A and F656A largely abolished the inhibition by nefazodone. The pore region mutant S624A mildly reduced the inhibition by nefazodone but T623A had little effect. A docking study showed that the aromatic rings of nefazodone interact with Y652 and F656 via π–π interactions, while an amine interacted with the S624 residue in the pore region. In conclusion, Y652 and F656 in the S6 domain play critical roles in nefazodone binding. - Highlights: • Nefazodone inhibits hERG channels with an IC{sub 50} of 45.3 nM in HEK-293 cells. • Nefazodone blocks hERG channels by binding to the open channels. • Y652 and F656 are important for binding of nefazodone. • The aromatic rings of nefazodone interact with Y652 and F656 via π–π interactions.

OSTI ID:
22285588
Journal Information:
Toxicology and Applied Pharmacology, Vol. 274, Issue 3; Other Information: Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
Journal Article · Fri Apr 01 00:00:00 EDT 2016 · Toxicology and Applied Pharmacology · OSTI ID:22285588

Mitragynine and its potential blocking effects on specific cardiac potassium channels
Journal Article · Mon Aug 15 00:00:00 EDT 2016 · Toxicology and Applied Pharmacology · OSTI ID:22285588

Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels
Journal Article · Sun May 01 00:00:00 EDT 2011 · Toxicology and Applied Pharmacology · OSTI ID:22285588